ALX Oncology Holdings Inc. (ALXO) — Stock Score Summary

ALX Oncology Holdings Inc. (ALXO) has a MoatMap StockRank of 38/100 based on Quality (31/100), Value (40/100), and Momentum (54/100) factor scores. The current signal is HOLD. ALX Oncology is a clinical-stage biotech with no commercialized products or cash flows. It is highly speculative and does not meet any of our quality or compounder criteria.

ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company dedicated to developing novel therapies that block the CD47 checkpoint pathway to enhance the immune system's attack on cancer. Its lead product candidate, ALX148, is designed as a potent CD47 blocker with an improved safety profile, positioning the company as a focused innovator in a challenging yet high-potential oncology therapeutic area.

Key Financial Metrics

Price$1.55
Market Cap$254M
P/E (Forward)-2.90
Price/Book1.39
Return on Equity-74.2%
Return on Invested Capital-290.2%
Debt/Equity5.62
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-43M

ALX Oncology Holdings Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is ALX Oncology Holdings Inc.’s (ALXO) StockRank?
MoatMap’s StockRank for ALX Oncology Holdings Inc. (ALXO) is 38/100, with a Hold signal. It is a composite of Quality (31), Value (40), and Momentum (54) factor ranks across MoatMap’s 19,000+ stock universe.
Does ALX Oncology Holdings Inc. have an economic moat?
ALX Oncology Holdings Inc. (ALXO) has a Quality factor score of 31/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is ALX Oncology Holdings Inc. a buy, hold, or sell?
MoatMap’s current signal for ALX Oncology Holdings Inc. (ALXO) is Hold, based on a StockRank of 38/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is ALX Oncology Holdings Inc. in?
ALX Oncology Holdings Inc. (ALXO) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksALXO deep dive reportAI ChampionsHow we score stocksSense-check another stock